The nature of the attenuation of Salmonella typhimurium strains expressing human papillomavirus type 16 virus-like particles determines the systemic and mucosal antibody responses in nasally immunized mice

Jalil Benyacoub, Sally Hopkins, Alexandra Potts, Sandra Kelly, Jean Pierre Kraehenbuhl, Roy Curtiss, Pierre De Grandi, Denise Nardelli-Haefliger

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

We have recently shown by using a recombinant Salmonella typhimurium PhoP(c) strain in mice the feasibility of using a Salmonella-based vaccine to prevent infection by the genital human papillomavirus type 16 (HPV16). Here, we compare the HPV16-specific antibody responses elicited by nasal immunization with recombinant S. typhimurium strains harboring attenuations that, in contrast to PhoP(c) are suitable for human use. For this purpose, χ4989 (Δcya Δcrp) and χ4990 [Δcya Δ(crp-cdt)] were constructed in the ATCC 14028 genetic background, and comparison was made with the isogenic PhoP(c) and PhoP- strains. Although the levels of expression of HPV16 virus- like particle (VLP) were similar in all strains, only PhoP(c) HPV16 induced sustained specific antibody responses after nasal immunization, while all strains induced high antibody responses with a single nasal immunization when an unrelated viral hepatitis B core antigen was expressed. The level of the specific antibody responses induced did not correlate with the number of recombinant bacteria surviving in various organs 2 weeks after immunization. Our data suggest that the immunogenicity of attenuated Salmonella vaccine strains does not correlate with either the number of persisting bacteria after immunization or the levels of in vitro expression of the antigen carried. Rather, the PhoP(c) phenotype appears to provide the unique ability in Salmonella to induce immune responses against HPV16 VLPs.

Original languageEnglish (US)
Pages (from-to)3674-3679
Number of pages6
JournalInfection and Immunity
Volume67
Issue number7
StatePublished - 1999
Externally publishedYes

Fingerprint

Papillomaviridae
Human papillomavirus 16
Salmonella typhimurium
Virion
Antibody Formation
Immunization
Salmonella Vaccines
Nose
Bacteria
Hepatitis B Core Antigens
Attenuated Vaccines
Salmonella
Phenotype
Antigens
Infection

ASJC Scopus subject areas

  • Immunology

Cite this

The nature of the attenuation of Salmonella typhimurium strains expressing human papillomavirus type 16 virus-like particles determines the systemic and mucosal antibody responses in nasally immunized mice. / Benyacoub, Jalil; Hopkins, Sally; Potts, Alexandra; Kelly, Sandra; Kraehenbuhl, Jean Pierre; Curtiss, Roy; De Grandi, Pierre; Nardelli-Haefliger, Denise.

In: Infection and Immunity, Vol. 67, No. 7, 1999, p. 3674-3679.

Research output: Contribution to journalArticle

Benyacoub, J, Hopkins, S, Potts, A, Kelly, S, Kraehenbuhl, JP, Curtiss, R, De Grandi, P & Nardelli-Haefliger, D 1999, 'The nature of the attenuation of Salmonella typhimurium strains expressing human papillomavirus type 16 virus-like particles determines the systemic and mucosal antibody responses in nasally immunized mice', Infection and Immunity, vol. 67, no. 7, pp. 3674-3679.
Benyacoub, Jalil ; Hopkins, Sally ; Potts, Alexandra ; Kelly, Sandra ; Kraehenbuhl, Jean Pierre ; Curtiss, Roy ; De Grandi, Pierre ; Nardelli-Haefliger, Denise. / The nature of the attenuation of Salmonella typhimurium strains expressing human papillomavirus type 16 virus-like particles determines the systemic and mucosal antibody responses in nasally immunized mice. In: Infection and Immunity. 1999 ; Vol. 67, No. 7. pp. 3674-3679.
@article{c99aef1ae767498abfab982d27913b8b,
title = "The nature of the attenuation of Salmonella typhimurium strains expressing human papillomavirus type 16 virus-like particles determines the systemic and mucosal antibody responses in nasally immunized mice",
abstract = "We have recently shown by using a recombinant Salmonella typhimurium PhoP(c) strain in mice the feasibility of using a Salmonella-based vaccine to prevent infection by the genital human papillomavirus type 16 (HPV16). Here, we compare the HPV16-specific antibody responses elicited by nasal immunization with recombinant S. typhimurium strains harboring attenuations that, in contrast to PhoP(c) are suitable for human use. For this purpose, χ4989 (Δcya Δcrp) and χ4990 [Δcya Δ(crp-cdt)] were constructed in the ATCC 14028 genetic background, and comparison was made with the isogenic PhoP(c) and PhoP- strains. Although the levels of expression of HPV16 virus- like particle (VLP) were similar in all strains, only PhoP(c) HPV16 induced sustained specific antibody responses after nasal immunization, while all strains induced high antibody responses with a single nasal immunization when an unrelated viral hepatitis B core antigen was expressed. The level of the specific antibody responses induced did not correlate with the number of recombinant bacteria surviving in various organs 2 weeks after immunization. Our data suggest that the immunogenicity of attenuated Salmonella vaccine strains does not correlate with either the number of persisting bacteria after immunization or the levels of in vitro expression of the antigen carried. Rather, the PhoP(c) phenotype appears to provide the unique ability in Salmonella to induce immune responses against HPV16 VLPs.",
author = "Jalil Benyacoub and Sally Hopkins and Alexandra Potts and Sandra Kelly and Kraehenbuhl, {Jean Pierre} and Roy Curtiss and {De Grandi}, Pierre and Denise Nardelli-Haefliger",
year = "1999",
language = "English (US)",
volume = "67",
pages = "3674--3679",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "7",

}

TY - JOUR

T1 - The nature of the attenuation of Salmonella typhimurium strains expressing human papillomavirus type 16 virus-like particles determines the systemic and mucosal antibody responses in nasally immunized mice

AU - Benyacoub, Jalil

AU - Hopkins, Sally

AU - Potts, Alexandra

AU - Kelly, Sandra

AU - Kraehenbuhl, Jean Pierre

AU - Curtiss, Roy

AU - De Grandi, Pierre

AU - Nardelli-Haefliger, Denise

PY - 1999

Y1 - 1999

N2 - We have recently shown by using a recombinant Salmonella typhimurium PhoP(c) strain in mice the feasibility of using a Salmonella-based vaccine to prevent infection by the genital human papillomavirus type 16 (HPV16). Here, we compare the HPV16-specific antibody responses elicited by nasal immunization with recombinant S. typhimurium strains harboring attenuations that, in contrast to PhoP(c) are suitable for human use. For this purpose, χ4989 (Δcya Δcrp) and χ4990 [Δcya Δ(crp-cdt)] were constructed in the ATCC 14028 genetic background, and comparison was made with the isogenic PhoP(c) and PhoP- strains. Although the levels of expression of HPV16 virus- like particle (VLP) were similar in all strains, only PhoP(c) HPV16 induced sustained specific antibody responses after nasal immunization, while all strains induced high antibody responses with a single nasal immunization when an unrelated viral hepatitis B core antigen was expressed. The level of the specific antibody responses induced did not correlate with the number of recombinant bacteria surviving in various organs 2 weeks after immunization. Our data suggest that the immunogenicity of attenuated Salmonella vaccine strains does not correlate with either the number of persisting bacteria after immunization or the levels of in vitro expression of the antigen carried. Rather, the PhoP(c) phenotype appears to provide the unique ability in Salmonella to induce immune responses against HPV16 VLPs.

AB - We have recently shown by using a recombinant Salmonella typhimurium PhoP(c) strain in mice the feasibility of using a Salmonella-based vaccine to prevent infection by the genital human papillomavirus type 16 (HPV16). Here, we compare the HPV16-specific antibody responses elicited by nasal immunization with recombinant S. typhimurium strains harboring attenuations that, in contrast to PhoP(c) are suitable for human use. For this purpose, χ4989 (Δcya Δcrp) and χ4990 [Δcya Δ(crp-cdt)] were constructed in the ATCC 14028 genetic background, and comparison was made with the isogenic PhoP(c) and PhoP- strains. Although the levels of expression of HPV16 virus- like particle (VLP) were similar in all strains, only PhoP(c) HPV16 induced sustained specific antibody responses after nasal immunization, while all strains induced high antibody responses with a single nasal immunization when an unrelated viral hepatitis B core antigen was expressed. The level of the specific antibody responses induced did not correlate with the number of recombinant bacteria surviving in various organs 2 weeks after immunization. Our data suggest that the immunogenicity of attenuated Salmonella vaccine strains does not correlate with either the number of persisting bacteria after immunization or the levels of in vitro expression of the antigen carried. Rather, the PhoP(c) phenotype appears to provide the unique ability in Salmonella to induce immune responses against HPV16 VLPs.

UR - http://www.scopus.com/inward/record.url?scp=0033008860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033008860&partnerID=8YFLogxK

M3 - Article

VL - 67

SP - 3674

EP - 3679

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 7

ER -